Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study
Xiaofei Qi, Xuewei Li, Ye Zhao, Xiaojin Wu, Feng Chen, Xiao Ma, Faming Zhang, Depei Wu, Xiaofei Qi, Xuewei Li, Ye Zhao, Xiaojin Wu, Feng Chen, Xiao Ma, Faming Zhang, Depei Wu
Abstract
Patients with steroid refractory gastrointestinal (GI) tract graft- vs.-host disease (GvHD) face a poor prognosis and limited therapeutic options. To accurately assess the efficacy and safety of fecal microbiota transplantation (FMT) in treating steroid refractory GI tract GvHD, we conducted a pilot study involving eight patients. Having received FMTs, all patients' clinical symptoms relieved, bacteria enriched, and microbiota composition reconstructed. Compared to those who did not receive FMT, these eight patients achieved a higher progression-free survival. FMT can serve as a therapeutic option for GI tract aGVHD, but its effectiveness and safety need further evaluations. Clinical Trial Registration: NCT03148743.
Keywords: a pilot study; diarrhea; fecal microbiota transplantations; graft-vs.-host disease; refractory gastrointestinal.
Figures
References
- Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. (2006) 354:1813–26. 10.1056/NEJMra052638
- Tuncer HH, Rana N, Milani C, Milani C, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. (2012) 18:1851–60. 10.3748/wjg.v18.i16.1851
- Weber D, Oefner PJ, Hiergeist A, Koestler J, Gessner A, Weber M, et al. . Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood (2015) 126:1723–8. 10.1182/blood-2015-04-638858
- Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R, et al. . Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation (1998) 66:1319–24. 10.1097/00007890-199811270-00010
- McDonald GB. How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. Blood (2016) 127:1544–50. 10.1182/blood-2015-10-612747
- Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et al. . First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. (2012) 18:150–63. 10.1016/j.bbmt.2012.04.005
- Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. . The gut microbiota and host health: a new clinical Frontier. Gut (2016) 65:330–9. 10.1136/gutjnl-2015-309990
- Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling LL, et al. . The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood (2014) 124:1174–82. 10.1182/blood-2014-02-554725
- Holler E, Butzhammer P, Schmid K, Hundsrucker CH, Koestler J, Peter K, et al. . Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. (2014) 20:640–5. 10.1016/j.bbmt.2014.01.030
- Spindelboeck W, Schulz E, Uhl B, Kashofer K, Aigelsreiter A, Zinke-Cerwenka W, et al. . Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica (2017) 102:210–3. 10.3324/haematol.2016.154351
- Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, et al. Fecal microbiota transplantation for patients with steroid-resistant/dependent acute graft-versus-host disease of the gut. Blood (2016) 128:2083–88. 10.1182/blood-2016-05-717652
- Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. (2013) 13:790–801. 10.1038/nri3535
- Nood EV, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. . Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. (2013) 368:407–15. 10.1056/NEJMoa1205037
- Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, et al. . Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile Infection: a randomized trial. Ann Intern Med. (2016) 165:609–16. 10.7326/M16-0271
- Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, et al. . Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. (1997) 97:855–64. 10.1046/j.1365-2141.1997.1112925.x
- Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. . 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. (1995) 15:825–8.
- Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, et al. . Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. (2015) 13:298–309. 10.1186/s12967-015-0646-2
- Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. (2016) 17:505–13. 10.1038/ni.3400
Source: PubMed